EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Epigenetic Role of Long Non-coding RNAs in Multiple Myeloma

Nikita Mehra, Subhiksha Sundaram, Parth Shah, Arunagiri Kuha Deva Magendhra Rao

Current Oncology Reports · 2025

DOI: 10.1007/s11912-024-01623-5 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Current Oncology Reports, 2025. Verfasst von Nikita Mehra und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Oncology & Molecular Oncology, Cancer Institute (WIA), Chennai, TN, India. nikita.mehra3@gmail.com. Hauptthemen laut MEDLINE: Multiple Myeloma, RNA, Long Noncoding, Epigenesis, Genetic. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 72 Literaturangaben. Gefördert von: Core Research Grant, DST-SERB.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE OF THE REVIEW: This review aims to explore the pivotal role of long non-coding RNAs (lncRNAs) as epigenetic regulators in the pathogenesis of multiple myeloma (MM). Additionally, we have portrayed the dual role of lncRNAs in the epigenetic landscape of MM pathobiology. RECENT FINDINGS: In MM, lncRNAs are pivotal for proliferation, progression, and drug resistance by acting as miRNA sponges, regulating mRNA activity through microRNA recognition elements (MREs). Epigenetic modifications in lncRNAs influence gene expression, with some like MEG3, GAS5, CRNDE, and H19 showing promoter hypermethylation, while MALAT1 exhibits hypomethylation. Targeting lncRNAs using siRNA, ASO, CRISPR-Cas9, or small molecule inhibitors shows promise in preclinical studies, alongside the potential benefits of epigenetic-based therapies such as DNMTi and HDACi. Clinical trials combining epigenetic modifiers with standard chemotherapy show encouraging results, especially in relapsed/refractory MM. The key finding of the studies highlighted in the review paves the way for understanding the epigenetic role of lncRNAs in MM disease progression and biology. In addition, the novel therapeutic strategies that have shown promising results have been highlighted. The adoption of the epigenetic landscape into therapeutics in addition to existing treatment strategies may increase the efficacy of treatment approaches.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Multiple MyelomaRNA, Long NoncodingEpigenesis, GeneticHumansGene Expression Regulation, NeoplasticDNA Methylation

Stichwörter der Autor:innen

EpigeneticsLong non-coding RNAsMultiple myelomaTherapeutic targets

Substanzen

RNA, Long Noncoding

Autor:innen und Institutionen

  • Department of Medical Oncology & Molecular Oncology, Cancer Institute (WIA), Chennai, TN, India. nikita.mehra3@gmail.com.
  • Department of Medical Oncology & Molecular Oncology, Cancer Institute (WIA), Chennai, TN, India.
  • Department of Pathology and Lab Medicine, Dartmouth Hitchcock Medical Center, Hanover, NH, USA.
  • Department of Molecular Oncology, Cancer Institute (WIA), Chennai, TN, India.

Förderung

  • Core Research Grant, DST-SERB

Zitieren

APA

Mehra, N., Sundaram, S., Shah, P., & Rao, A. K. D. M. (2025). Epigenetic Role of Long Non-coding RNAs in Multiple Myeloma. Current Oncology Reports. https://doi.org/10.1007/s11912-024-01623-5

Vancouver

Mehra N, Sundaram S, Shah P, Rao AKDM. Epigenetic Role of Long Non-coding RNAs in Multiple Myeloma. Current Oncology Reports. 2025. doi:10.1007/s11912-024-01623-5

BibTeX
@article{Mehra2025,
  author = {Mehra, Nikita and Sundaram, Subhiksha and Shah, Parth and Rao, Arunagiri Kuha Deva Magendhra},
  title = {Epigenetic Role of Long Non-coding RNAs in Multiple Myeloma},
  journal = {Current Oncology Reports},
  year = {2025},
  doi = {10.1007/s11912-024-01623-5}
}
Kostenlos starten →